These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16848380)

  • 41. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation.
    McIntyre HF
    Int J Clin Pract; 2009 Jan; 63(1):7-14. PubMed ID: 19125987
    [No Abstract]   [Full Text] [Related]  

  • 43. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
    Klein R; Moss SE; Sinaiko AR; Zinman B; Gardiner R; Suissa S; Donnelly SM; Kramer MS; Goodyer P; Strand T; Mauer M
    Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G; Sciarretta S; Facciolo C; Volpe M
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetic nephropathy. A modifiable risk factor].
    Madsbad S
    Ugeskr Laeger; 2000 Sep; 162(38):5053. PubMed ID: 11014131
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diabetes and the kidneys].
    Hohenstein B; Hugo C
    Dtsch Med Wochenschr; 2012 Oct; 137(40):1998-2001. PubMed ID: 23023609
    [No Abstract]   [Full Text] [Related]  

  • 49. The road to renal failure: an overview of diabetic nephropathy.
    McCrary EB
    Adv Nurse Pract; 2008 Jul; 16(7):61-3. PubMed ID: 19181161
    [No Abstract]   [Full Text] [Related]  

  • 50. On call. My doctor prescribed Zestril for me because I have diabetes, even though my blood pressure has always been normal. I am 54, and my blood sugar came down to normal on pills. Do I really need another medicine?
    Simon HB
    Harv Mens Health Watch; 2003 Aug; 8(1):8. PubMed ID: 12936865
    [No Abstract]   [Full Text] [Related]  

  • 51. ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?
    Kelleher CC
    Drugs; 1990 May; 39(5):639-45. PubMed ID: 2191846
    [No Abstract]   [Full Text] [Related]  

  • 52. [Enhancing the study of prevention and treatment of diabetic nephropathy].
    Li N
    Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):327-8. PubMed ID: 11715468
    [No Abstract]   [Full Text] [Related]  

  • 53. ARBs provide renal protection in type 2 diabetes.
    Geriatrics; 2001 Sep; 56(9):17, 20. PubMed ID: 11582969
    [No Abstract]   [Full Text] [Related]  

  • 54. Diabetic nephropathy.
    Shlipak M
    Clin Evid; 2005 Dec; (14):441-54. PubMed ID: 16620414
    [No Abstract]   [Full Text] [Related]  

  • 55. ACE giveaway could save lives, money.
    Harv Heart Lett; 2005 Oct; 16(2):6. PubMed ID: 16299905
    [No Abstract]   [Full Text] [Related]  

  • 56. . . . and people with diabetes.
    Health News; 1999 Dec; 5(15):5. PubMed ID: 10633585
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention of the progression of diabetic nephropathy with antihypertensive treatment].
    Moulin B
    Therapie; 1997; 52(5):459-60. PubMed ID: 9501576
    [No Abstract]   [Full Text] [Related]  

  • 58. Can we prevent or delay diabetic nephropathy?
    Bilous RW
    J R Coll Physicians Lond; 1997; 31(1):22-7. PubMed ID: 9044193
    [No Abstract]   [Full Text] [Related]  

  • 59. Should all patients with diabetes mellitus receive angiotensin-converting enzyme inhibitors?
    Eledrisi MS
    Endocr Pract; 2005; 11(3):209. PubMed ID: 16239212
    [No Abstract]   [Full Text] [Related]  

  • 60. Diabetic nephropathy.
    Bloomgarden ZT
    Diabetes Care; 2005 Mar; 28(3):745-51. PubMed ID: 15735220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.